FERDINANDOS SKOULIDIS to Molecular Targeted Therapy
This is a "connection" page, showing publications FERDINANDOS SKOULIDIS has written about Molecular Targeted Therapy.
Connection Strength
0.266
-
Targeting the Gatekeeper: Osimertinib in EGFR T790M Mutation-Positive Non-Small Cell Lung Cancer. Clin Cancer Res. 2017 Feb 01; 23(3):618-622.
Score: 0.266
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.